The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Thin Film Drug-Global Market Insights and Sales Trends 2024
Synopsis
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The global Thin Film Drug market size is expected to reach US$ 8696.3 million by 2029, growing at a CAGR of 1.7% from 2023 to 2029. The market is mainly driven by the significant applications of Thin Film Drug in various end use industries. The expanding demands from the Hospitals, Drugstores and Others,, are propelling Thin Film Drug market. Oral Thin Film, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transdermal Thin Film segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thin Film Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thin Film Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thin Film Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thin Film Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thin Film Drug covered in this report include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec and Tapemark, etc.
The global Thin Film Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx
APR
Global Thin Film Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thin Film Drug market, Segment by Type:
Oral Thin Film
Transdermal Thin Film
Others
Global Thin Film Drug market, by Application
Hospitals
Drugstores
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thin Film Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
The global Thin Film Drug market size is expected to reach US$ 8696.3 million by 2029, growing at a CAGR of 1.7% from 2023 to 2029. The market is mainly driven by the significant applications of Thin Film Drug in various end use industries. The expanding demands from the Hospitals, Drugstores and Others,, are propelling Thin Film Drug market. Oral Thin Film, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transdermal Thin Film segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Thin Film Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Thin Film Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Thin Film Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Thin Film Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Thin Film Drug covered in this report include GSK, LTS, J&J, Indivior, Pfizer, Sanofi, Church & Dwight, tesa Labtec and Tapemark, etc.
The global Thin Film Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx
APR
Global Thin Film Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Thin Film Drug market, Segment by Type:
Oral Thin Film
Transdermal Thin Film
Others
Global Thin Film Drug market, by Application
Hospitals
Drugstores
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Thin Film Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Thin Film Drug
1.1 Thin Film Drug Market Overview
1.1.1 Thin Film Drug Product Scope
1.1.2 Thin Film Drug Market Status and Outlook
1.2 Global Thin Film Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Thin Film Drug Market Size by Region (2018-2029)
1.4 Global Thin Film Drug Historic Market Size by Region (2018-2023)
1.5 Global Thin Film Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Thin Film Drug Market Size (2018-2029)
1.6.1 North America Thin Film Drug Market Size (2018-2029)
1.6.2 Europe Thin Film Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Thin Film Drug Market Size (2018-2029)
1.6.4 Latin America Thin Film Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Thin Film Drug Market Size (2018-2029)
2 Thin Film Drug Market by Type
2.1 Introduction
2.1.1 Oral Thin Film
2.1.2 Transdermal Thin Film
2.1.3 Others
2.2 Global Thin Film Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Thin Film Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Thin Film Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Thin Film Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Thin Film Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Thin Film Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Thin Film Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Thin Film Drug Revenue Breakdown by Type (2018-2029)
3 Thin Film Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Drugstores
3.1.3 Others
3.2 Global Thin Film Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Thin Film Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Thin Film Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Thin Film Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Thin Film Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Thin Film Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Thin Film Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Thin Film Drug Revenue Breakdown by Application (2018-2029)
4 Thin Film Drug Competition Analysis by Players
4.1 Global Thin Film Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Thin Film Drug as of 2022)
4.3 Date of Key Players Enter into Thin Film Drug Market
4.4 Global Top Players Thin Film Drug Headquarters and Area Served
4.5 Key Players Thin Film Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Thin Film Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Thin Film Drug Products, Services and Solutions
5.1.4 GSK Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 LTS
5.2.1 LTS Profile
5.2.2 LTS Main Business
5.2.3 LTS Thin Film Drug Products, Services and Solutions
5.2.4 LTS Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.2.5 LTS Recent Developments
5.3 J&J
5.3.1 J&J Profile
5.3.2 J&J Main Business
5.3.3 J&J Thin Film Drug Products, Services and Solutions
5.3.4 J&J Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Indivior Recent Developments
5.4 Indivior
5.4.1 Indivior Profile
5.4.2 Indivior Main Business
5.4.3 Indivior Thin Film Drug Products, Services and Solutions
5.4.4 Indivior Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Indivior Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer Thin Film Drug Products, Services and Solutions
5.5.4 Pfizer Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Pfizer Recent Developments
5.6 Sanofi
5.6.1 Sanofi Profile
5.6.2 Sanofi Main Business
5.6.3 Sanofi Thin Film Drug Products, Services and Solutions
5.6.4 Sanofi Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Sanofi Recent Developments
5.7 Church & Dwight
5.7.1 Church & Dwight Profile
5.7.2 Church & Dwight Main Business
5.7.3 Church & Dwight Thin Film Drug Products, Services and Solutions
5.7.4 Church & Dwight Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.7.5 Church & Dwight Recent Developments
5.8 tesa Labtec
5.8.1 tesa Labtec Profile
5.8.2 tesa Labtec Main Business
5.8.3 tesa Labtec Thin Film Drug Products, Services and Solutions
5.8.4 tesa Labtec Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.8.5 tesa Labtec Recent Developments
5.9 Tapemark
5.9.1 Tapemark Profile
5.9.2 Tapemark Main Business
5.9.3 Tapemark Thin Film Drug Products, Services and Solutions
5.9.4 Tapemark Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Tapemark Recent Developments
5.10 Prestige Bands
5.10.1 Prestige Bands Profile
5.10.2 Prestige Bands Main Business
5.10.3 Prestige Bands Thin Film Drug Products, Services and Solutions
5.10.4 Prestige Bands Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Prestige Bands Recent Developments
5.11 Sun Pharma
5.11.1 Sun Pharma Profile
5.11.2 Sun Pharma Main Business
5.11.3 Sun Pharma Thin Film Drug Products, Services and Solutions
5.11.4 Sun Pharma Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Sun Pharma Recent Developments
5.12 MonoSol
5.12.1 MonoSol Profile
5.12.2 MonoSol Main Business
5.12.3 MonoSol Thin Film Drug Products, Services and Solutions
5.12.4 MonoSol Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.12.5 MonoSol Recent Developments
5.13 BioDelivery
5.13.1 BioDelivery Profile
5.13.2 BioDelivery Main Business
5.13.3 BioDelivery Thin Film Drug Products, Services and Solutions
5.13.4 BioDelivery Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.13.5 BioDelivery Recent Developments
5.14 Arx
5.14.1 Arx Profile
5.14.2 Arx Main Business
5.14.3 Arx Thin Film Drug Products, Services and Solutions
5.14.4 Arx Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.14.5 Arx Recent Developments
5.15 ZIM
5.15.1 ZIM Profile
5.15.2 ZIM Main Business
5.15.3 ZIM Thin Film Drug Products, Services and Solutions
5.15.4 ZIM Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.15.5 ZIM Recent Developments
5.16 NAL Pharma
5.16.1 NAL Pharma Profile
5.16.2 NAL Pharma Main Business
5.16.3 NAL Pharma Thin Film Drug Products, Services and Solutions
5.16.4 NAL Pharma Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.16.5 NAL Pharma Recent Developments
5.17 AdhexPharma
5.17.1 AdhexPharma Profile
5.17.2 AdhexPharma Main Business
5.17.3 AdhexPharma Thin Film Drug Products, Services and Solutions
5.17.4 AdhexPharma Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.17.5 AdhexPharma Recent Developments
5.18 Aavishkar
5.18.1 Aavishkar Profile
5.18.2 Aavishkar Main Business
5.18.3 Aavishkar Thin Film Drug Products, Services and Solutions
5.18.4 Aavishkar Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.18.5 Aavishkar Recent Developments
5.19 IntelGenx
5.19.1 IntelGenx Profile
5.19.2 IntelGenx Main Business
5.19.3 IntelGenx Thin Film Drug Products, Services and Solutions
5.19.4 IntelGenx Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.19.5 IntelGenx Recent Developments
5.20 APR
5.20.1 APR Profile
5.20.2 APR Main Business
5.20.3 APR Thin Film Drug Products, Services and Solutions
5.20.4 APR Thin Film Drug Revenue (US$ Million) & (2018-2023)
5.20.5 APR Recent Developments
6 North America
6.1 North America Thin Film Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Thin Film Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Thin Film Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Thin Film Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Thin Film Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Thin Film Drug Market Dynamics
11.1 Thin Film Drug Industry Trends
11.2 Thin Film Drug Market Drivers
11.3 Thin Film Drug Market Challenges
11.4 Thin Film Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
